8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Apr 28, 2026 · 2mo ago · Accession 0001104659-26-049733
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- 8-K
- Filing date
- Apr 28, 2026
- Report date
- Apr 28, 2026
- Document
- acrs-20260428x8k.htm
- Size
- 5.8 MB